EPIDEMIC influenza has been characterized throughout history by its ability to kill. The extent of this mortality has, of course, varied from outbreak to outbreak so that it is impossible to provide any meaningful statistics. Indeed, so far as the entire country is concerned, the number of deaths appears to be determined as much by the total morbidity as by the time of year of the outbreak or the particular population group. Kilbourne (I960) has gone so far as to suggest that the influenza virus has not altered appreciably in regard to its intrinsic virulence for man in the past 50 years, morbidity being determined by immunological factors and mortality by abnormalities of the host or his environment. This is a suggestion which might well occasion a heated debate particularly as we have yet to decide upon a laboratory method of defining virus virulence which would enable us to classify strains. It is, however worthwhile emphasizing the point which emerged abundantly during the first waves of the A2 influenza era, namely that complications then occurred particularly among those in the older age-groups with chronic disease of the heart or lung. The host appears therefore to be all important in the determination of the incidence of fatal complications of influenza. This was indeed obvious even before the Asian virus era, for during influenza epidemics deaths from all causes rise and although the largest separate increase is in respiratory complications, deaths due to hypertension, rheumatic heart disease, chronic nephritis, and diabetes, all show an increase often known as the excess mortality of influenza. Influenzal bronchiolitis is characterized by a more prolonged pyrexia than the ordinary case, by dyspncea and slight cyanosis and by abundant rales varying from fine to coarse over wide areas of the lung. Cough is productive of a mucopurulent or frankly purulent sputum. Sometimes the sputum is viscid, the bronchioles are plugged with secretion, and breath-sounds over the affected area are reduced. The radiograph is essentially normal. Virus is readily demonstrable in patients with bronchiolitis, for the air-passage involve-ment occurs synchronously with the disease. The sputum does not usually contain pneumococci but Haemophilus influenzae may or may not be present. In a series of 17 cases of bronchiolitis seen in I937 the past histories of the patients were examined carefully in order to determine whether the complication was the result of previous chest disease. Four patients only gave a history of such illness; two had had previous bronchitis, one an attack of pneumonia in childhood and one had pleurisy a year before the influenza. Perhaps the important fact is that I3 patients had no previous chest abnormality and that influenzal bronchiolitis ought to be regarded as a feature of the virus infection in previously well adults.
Influenzal pneumonia is of two main varieties occurring respectively synchronously with and after the influenza virus infection. One cannot conclude this account of the pulmonary complications without reference to the importance of the host in their determination. Pregnancy, heart disease and chronic bronchitis are the three chief associates of severe or fatal influenzal pneumonia (Louria, Blumenfeld, Ellis, Kilbourne and Rogers, 1959; Robertson, Caley and Moore, 1958) . Whether the virus lesions of the respiratory tract cause death from obstructive bronchitis or because of an effect on the circulation remains to be considered.
Cardiac Complications
It has always been known that patients with existing heart disease such as mitral stenosis, hypertension or ischiemia tolerate influenza poorly. Perhaps the extent of the deterioration likely to occur was not adequately appreciated before I957 but numerous papers appeared after the first wave indicating the gravity of influenzal pneumonia in cardiac cases. In Leeds the distinctive character of the clinical picture of influenzal pneumonia in mitral stenosis was pictured by Newcombe, Nixon and Thompson (1958) . Severe dyspnea, himoptysis and congestive heart failure were noted. Radiological opacities of a multiple and ill-defined character resembling pulmonary cedema were seen. Three of the nine patients died. The effect of influenza in patients with other forms of pre-existing heart disease has not attracted so much attention as that of mitral stenosis. However, congestive cardiac failure at times is clearly dated from an attack of influenza in patients with any form of heart disease and particularly with chronic cor pulmonale. The mechanism of this does not appear to be a specific effect of influenza virus infection.
Cardiac complications in patients without preexisting heart disease are, however, uncommon. Pericarditis and myocarditis have been described infrequently (Finland, Parker, Barnes and Joliffe, I945) . Adams (I959) described eight cases of socalled benign non-specific pericarditis occurring after either influenza B or influenza A infection. Bacteria did not appear to be concerned in these abnormalities but pericarditis certainly occurs in some patients with staphylococcal pneumonia. Studies of the effect of Asian influenza on the normal circulatory system were made by Walsh, Burch, White, Mogabgab and Dietlein (1958) . The first study of 30 patients with influenza admitted to hospital included 20 with uncomplicated disease and ten with pulmonary involvement. Abnormal electrocardiographic findings consisting of T-wave changes without any impairment of conduction and changes in the vectorcardiogram were noted in a proportion of the patients including uncomplicated cases. Gibson, Arnold, Craige, and Curnen (I959) studied 87 university students and found I2 with electrocardiograms which were rated abnormal because of S-T segment deviations, T-wave depression, and arrhythmias. Four of the I2 patients had abnormalities only during convalescence. These American authors think that their findings support the existence of a myocarditis due to influenza virus which is clinically overlooked. Probably this is a matter requiring much more work for though influenza virus has been recovered from the heart muscle in patients dying from influenzal pneumonia (Kaji, Oseasohn, Jordan and Dingle, I959) it seems probable that this is due to an agonal viraemia. The more plausible effect of 'toxemia' is equally difficult to sustain. Apart from its pyrogenic action, influenza virus requires to be given in enormous doses to demonstrate a toxic effect in mice and then the liver, the brain and lung appear to be the chief targets (Henle and Henle, I946) .
Neurological Complications
The evidence for association between influenza and neurological disease has in the past been circumstantial and untrustworthy because of the lack of laboratory data. Encephalitis as a cause of death has occurred after o.8 to 1.2 cases per i,000 influenza deaths in the years from I950 onwards. This is probably similar to the reported frequency of measles encephalitis of i per I,000 cases though these are not of course all fatal. In 1957, a new phenomenon appeared, namely an incidence of fatal encephalitis of 3.6 per i,ooo influenza deaths. Numerous articles appeared in the press and none were more convincing than the papers by Flewett and Hoult (1958) 
Conclusion
Influenza virus infection falls on the healthy and abnormal population equally. Though it causes complications much more frequently in those with pre-existing heart or chest disease, its effect as an initiator of disease of the lungs in those with previously good health must not be overlooked. This summary of the chief clinical complications has left little time to refer to otitis media, labyrinthitis or sinusitis. Of these perhaps acute labyrinthitis is a syndrome following upper respiratory disease which has a particularly striking character. Like otitis media however, there is no evidence linking it specifically with influenza virus.
